PEG-Carbohydrate-Lipid Conjugates for Drug Solubility and Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery systems face challenges with achieving therapeutic concentrations at target sites due to high dosages required for systemic administration, leading to side effects, and many drugs have issues with water solubility and permeability, which hinder their ability to reach their site of action effectively.
Innovation Solution
The development of polymer-carbohydrate-lipid conjugates, specifically PEG-carbohydrate-lipid conjugates, which combine a backbone with appended lipid, hydrophilic polymer, and carbohydrate functionalities to enhance solubility and targeting capabilities, using monodisperse PEG chains and varied linkers for optimized drug delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high dosages are used for systemic administration to achieve therapeutic concentrations at target sites, then therapeutic effect is improved, but side effects increase
Solution Approach 1:
The patent divides the drug delivery system into distinct functional components: a hydrophobic drug core, a PEGylated lipid shell, and carbohydrate targeting moieties. This segmentation allows the drug to be delivered in controlled amounts directly to the target site, reducing the need for high systemic dosages and minimizing side effects while maintaining therapeutic efficacy.
Solution Approach 2:
The PEG-carbohydrate-lipid conjugate acts as an intermediary carrier between the hydrophobic drug and the aqueous biological environment. This mediator solubilizes the drug, enables targeted delivery through carbohydrate-receptor interactions, and controls drug release, thereby improving therapeutic effect at lower dosages and reducing systemic side effects.
2Ease of operation
If conventional drug formulations are used, then ease of administration is maintained, but water solubility and permeability issues hinder effective drug delivery
Solution Approach 1:
The patent employs composite PEG-carbohydrate-lipid conjugates that combine hydrophilic PEG chains, hydrophobic lipid tails, and carbohydrate targeting groups. This composite structure simultaneously solubilizes hydrophobic drugs in aqueous environments, provides targeted delivery capability, and maintains ease of parenteral administration while dramatically improving drug delivery effectiveness to target tissues.
3Reliability
If PEG is used as a water soluble carrier for polymer-drug conjugates, then solubility and biocompatibility are improved, but the polymer is non-biodegradable
Solution Approach 1:
The patent modifies the PEG-lipid conjugate structure by incorporating hydrolyzable ester bonds in the lipid backbone and attaching biodegradable carbohydrate moieties. These parameter changes maintain the solubility and biocompatibility benefits of PEG while introducing controlled biodegradability, allowing the carrier to break down into harmless metabolites after drug delivery is complete.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These conjugates improve drug solubility and stability, reduce the need for high dosages, and enhance targeted delivery, minimizing side effects and improving bioavailability, as demonstrated by their use in formulations like Propofol, where they form stable emulsified suspensions or solutions, and are effective in both intravenous and oral administration.
Implementation Method 1
The conjugates improve drug solubility and stability, reduce the need for high dosages, and enhance targeted delivery... as demonstrated by their use in formulations like Propofol, where they form stable emulsified suspensions or solutions
Data Source
AI summary
The invention comprises compounds, methods of making, and methods of using. The compounds may have a backbone and three appended functional groups: one lipid, one hydrophilic polymer, and one carbohydrate. Specific functional groups may be selected for specific applications in formulating pharmaceuticals, cosmetics, nutriceuticals, and the like. A variety of linkers between the backbone and functional groups may also be selected to optimize performance.